-
LamotrigineCAS No.: 84057-84-1. Molecular Formula: C9H7Cl2N5. Molecular Weight: 256.09 g/molread more
-
MethocarbamolAPI: Methocarbamol CAS No: 532-03-6 Therapeutic Category: Central muscle relaxant Specification:USP latest Regulatory status: Active in FDA, ready DMF/ASMF; Availability: Ready stocksread more
-
GuaifenesinGuaifenesin is an ingredient in cough and cold medicines that is used to help clear mucus or phlegm from your chest when you have had a cold or flu. Guaifenesin works by making your mucus thinner andread more
-
OmeprazoleCAS No. 73590-58-6. Molecular Formula: C17H19N3O3S. Molecular Weight: 345.42 g/molread more
-
Memantine HydrochlorideCAS No. 41100-52-1. Molecular Formula: C12H21N.HCl. Molecular Weight: 215.76 g/molread more
-
AripiprazoleCAS Number: 129722-12-9. Molecular Formula: C23H27Cl2N3O2. Molecular Weight: 448.38 g/mol (Free base)read more
-
Moxifloxacin HydrochlorideCAS No. 186826-86-8. Molecular Formula: C21H24FN3O4 · HCl. Molecular Weight: 437.90 g/molread more
-
Valacyclovir HydrochlorideCAS No. 124832-27-5. Molecular Formula: C13H20N6O4·HCl. Molecular Weight: 360.80 g/molread more
WebJun 23, 2023 · Tirzepatide (or matching placebo) was initiated at 2·5 mg once weekly and increased by 2·5 mg every 4 weeks until the target dose was reached (ie, 10 mg or 15...
WebMay 13, 2022 · Today, the U.S. Food and Drug Administration approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as...
WebSep 13, 2022 · Initial dose: 2.5 mg subcutaneously once a week. After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week. If additional glycemic control is needed: The...
WebMounjaro (tirzepatide) is injected under the skin and used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It was approved by the FDA in May 2022 as...
WebMay 1, 2023 · Tirzepatide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. Tirzapatide is a glucagon-like peptide-1 (GLP-1)...
WebThe Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials Diabetes Ther. 2021 Jan;12(1):143-157.doi:...
